Patient-level moderators of the efficacy of peer support and pager reminder interventions to promote antiretroviral adherence

AIDS and Behavior

Volumn 15, Issue 8, 2011, Pages 1596-1604

  Yard, Samantha S ^a   Huh, David ^a   King, Kevin M ^a   Simoni, Jane M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HAART; HIV AIDS; Medication adherence; Pager; Peers

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INTERVENTION STUDY; INTERVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PEER GROUP; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMINDER SYSTEM; SELF REPORT; SOCIOECONOMICS; THEORETICAL MODEL; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTERPERSONAL RELATIONS; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, THEORETICAL; PEER GROUP; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMINDER SYSTEMS; SELF REPORT; SOCIOECONOMIC FACTORS; VIRAL LOAD;

EID: 84555219928     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0001-4     Document Type: Article

References (63)

1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450-4. (Pubitemid 28082255)
2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853-60. (Pubitemid 28135961)
3. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: A systematic review of developed and developing nation patientreported barriers and facilitators. Plos Med. 2006;3(11):e438.
4. Friedland GH, Williams A. Attaining higher goals in HIV treatment: The central importance of adherence. AIDS. 1999; 13(Suppl 1):S61-72. (Pubitemid 29516023)
5. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Method. 1995;57(1):289-300.
6. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the international AIDS society-USA panel. JAMA. 1997;277(24): 1962-9. (Pubitemid 27272775)
7. Clavel F, Hance AJ. HIV drug resistance. N Engl J Med. 2004;350(10):1023-35. (Pubitemid 38269279)
8. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Educ Couns. 2002;46(2): 93-108. (Pubitemid 34175086)
9. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev [Internet]. 2000;(2). Available from: Http://www.ncbi.nlm.nih.gov/ pubmed/10796686.
10. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23-35. (Pubitemid 44885639)
11. Amico RK, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions. J Acquir Immune Defic Syndr. 2006;41(3):285-97.
12. Haddad M, Inch C, Glazier RH, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2000;(3):CD001442.
13. Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: A systematic review. AIDS Patient Care STDs. 2008;22(6):495-504.
14. Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: A systematic review and meta-analysis of randomised clinical trials. Lancet. 2009;374(9707):2064-71.
15. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS. 2005;19(8):807-14. (Pubitemid 40834751)
16. Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46(2): 238-44. (Pubitemid 47482621)
17. Simoni JM, Chen W, Huh D, et al. A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China. AIDS Behav [Internet]. 2010. Available from: Http://www.ncbi.nlm.nih.gov/pubmed/20957423.
18. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): A randomised trial. Lancet. 2010;376(9755): 1838-45.
19. Sabin LL, DeSilva MB, Hamer DH, et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav. 2009;14(3): 580-9.
20. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr. 2002; 31(Suppl 3):S123-7. (Pubitemid 35453571)
21. Chander G, Lau B, Moore RD. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411-7. (Pubitemid 44737097)
22. Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther (Lond). 2005;10(1): 83-93. (Pubitemid 40767634)
23. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-7. (Pubitemid 30482715)
24. Sabaté E, World Health Organization. Adherence to long-term therapies: Evidence for action [Internet]. Geneva: World Health Organization; 2003. Available from: Http://apps.who.int/medicine docs/en/d/Js4883e/.
25. Lovejoy TI, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review. J Behav Med. 2009;32(5):389-405.
26. Cleary S. Equity and efficiency in scaling up access to HIVrelated interventions in resource-limited settings. Curr Opin HIV AIDS. 2010;5(3):210-4.
27. Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: A randomized controlled trial. J Acquir Immune Defic Syndr. 2009;52(4):465-73.
28. Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443-50. (Pubitemid 350098695)
29. Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS. 2009;23(8):603-9.
30. Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S35-47. (Pubitemid 350293779)
31. Davies SL, Horton TV, Williams AG, Martin MY, Stewart KE. MOMS: Formative evaluation and subsequent intervention for mothers living with HIV. AIDS Care. 2009;21(5):552-60.
32. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Method. 2002;7(1):19-40.
33. Graves MM, Roberts MC, Rapoff M, Boyer A. The efficacy of adherence interventions for chronically ill children: A meta-analytic review. J Pediatr Psychol. 2009;35(4):368-82.
34. Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: Meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49(4):447-62.
35. Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc. 2009;49(6):760-8.
36. Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIVinfected patients: The GEEMA study. AIDS. 2002;16(4):605-13. (Pubitemid 34218856)
37. Raudenbush SW, Bryk A, Cheong YF, Congdon R. HLM 6 for Windows [Computer software]. Lincolnwood, IL: Scientific Software International Inc.; 2004 [cited 2010 Nov 16]. Available from: Http://www.ssicentral.com/hlm/references.html.
38. Raudenbush S, Bryk A. Hierarchical linear models: Applications and data analysis methods. 2nd ed. Thousand Oaks: Sage Publications; 2002.
39. Williams VSL, Jones LV, Tukey JW. Controlling error in multiple comparisons, with examples from state-to-state differences in educational achievement. J Educ Behav Stat. 1999;24(1): 42-69. doi:10.2307/1165261.
40. Thissen D, Steinberg L, Kuang D. Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. J Educ Behav Stat. 2002;27(1):77-83.
41. Stirratt M, Gordon C. HIV treatment adherence research and intervention: Current advances and future challenges. J HIV AIDS Soc Serv. 2007;6(1-2):9-22. (Pubitemid 46592517)
42. Ailinger RL, Black PL, Lima-Garcia N. Use of electronic monitoring in clinical nursing research. Clin Nurs Res. 2008;17(2): 89-97.
43. Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and selfreport: An examination of key methodological issues. AIDS Behav. 2007;11(2):161-73.
44. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968-77. (Pubitemid 32466236)
45. Spybrook J, Raudenbush SW, Congdon R, Martinez A. optimal design for longitudinal and multilevel research: Documentation for the ''Optimal Design'' Software [Internet]. 2009 Jul [cited 2010 Dec 31]. Available from: Http://www.wtgrantfdn.org/ resources/overview/research-tools/research-tools.
46. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum Associates; 1988.
47. Baruch DE, Kanter JW, Bowe WM, Pfennig SL. Improving homework compliance in career counseling with a behavioral activation functional assessment procedure: A pilot study. Cogn Behav Pract. 2011;18(2):256-66. doi:10.1016/j.cbpra.2010.04. 003.
48. Janson SL, McGrath KW, Covington JK, Cheng S, Boushey HA. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol. 2009;123(4):840-6.
49. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14.
50. Grasmick HG, Tittle CR, Bursik RJ, Arneklev BJ. Testing the core empirical implications of Gottfredson and Hirschi's general theory of crime. J Res Crime Delinq. 1993;30(1):5-29. (Pubitemid 23056427)
51. Vaux A, Burda P, Stewart D. Orientation toward utilization of support resources. J Community Psychol. 1986;14(2):159-70.
52. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171-6. (Pubitemid 32268984)
53. Crowne D, Marlowe D. The approval motive: studies in evaluative dependence. Westport: Greenwood Press; 1980.
54. LifeWindows Project Team. The life windows information motivation behavioral skills ART adherence questionnaire [Internet]. 2006 [cited 2010 Nov 20]. Available from: Http:// www.chip.uconn.edu/int/F-LWIMBARTQuestionnaire.pdf.
55. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3): 385-401.
56. Spielberger CD. Manual for the state-trait anxiety inventory: STAI (Form Y). Palo Alto: Consulting Psychologists Press; 1983.
57. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-96.
58. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT):WHOcollaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6): 791-804. (Pubitemid 23194530)
59. Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363-71. (Pubitemid 13162181)
60. Wilson IB, Kaplan S. Physician-patient communication in HIV disease: The importance of patient, physician, and visit characteristics. J Acquir Immune Defic Syndr. 2000;25(5):417-25. (Pubitemid 32063033)
61. Bakken S, Holzemer WL, Brown M, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDs. 2000;14(4):189-97. (Pubitemid 30225313)
62. Holland JC, Kash KM, Passik S, et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psychooncology. 1998;7(6):460-9. (Pubitemid 29012718)
63. Hays R, Sherbourne CD, Mazel R. User's manual for the medical outcomes study (MOS) core measures of health-related quality of life. Santa Monica: Rand Corp; 1995.